DalsnaFinance › IPOs › Taysha Gene Therapies Inc › IPO
Taysha Gene Therapies, Inc. completed its initial public offering on NASDAQ on September 24, 2020, pricing at $20.00 a share.
| Ticker | TSHA |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | September 24, 2020 |
| Offering price | $20.00 |
| Shares offered | 7,869,566 |
| Total raised | $157M |
Taysha Gene Therapies, Inc. sold 7,869,566 shares at $20.00 each on NASDAQ. Multiplied out, that is $157.4 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $157 million total recorded for the deal.
Taysha Gene Therapies, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Taysha Gene Therapies, Inc.. This page is general information, not investment advice.